The global demand for Dry Eye Syndrome Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period of 2022 - 2028.
Dry eye syndrome is a chronic condition characterized by insufficient moisture or lubrication on the eyes' surface. Also called keratoconjunctivitis sicca (KCS), it can lead to ocular discomfort and visual impairment. The most common reason for dry eyes is aging leading to a gradual decrease in tear production. Other causes for this syndrome include side effects of certain drugs like antihistamines, Sjogren's syndrome, contact lens use, rheumatoid arthritis, environmental conditions. The common symptoms experienced are dryness, stinging or tired eyes, burning, and sandy-gritty eye irritation. Both eyes are generally affected, and the treatment options include eye drops, topical steroids, and surgery in severe cases.
Market Dynamics
The growing emphasis on the treatment of dry eye syndrome due to its severity and its potential to affect one's vision is the critical trend creating several opportunities for market growth. The increased investment in the R & D of various treatment options will positively impact this market's growth. The presence of several reimbursement policies and recent advancements in clinical trials will favor this market's development. The rising geriatric population, steady growth in contact lens use, high prevalence of diseases affecting the eyes, and increased screen-related visually demanding tasks will benefit market growth. The various barriers to this market's growth are failing to realize the importance of diagnosis and treatment and low accessibility to eye care services.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of dry eye syndrome.
Market Segmentation
The report segments the anthracite market and analyses it with respect to the geography, intending to keep the marketer informed and help them identify the target demographics for the product or service.
By Type
- Evaporative Dry Eye Syndrome
- Aqueous Dry Eye Syndrome
By Diagnosis
- Schirmer Test
- Eye Exam
- Others
By Treatment
- Nutritional Supplements
- Serum Eye Drops
- Lubricant Eye Drops
- Anti-Inflammatory Drugs Segments
- Surgery
- Others
By End User
- Hospitals
- Clinics
- Home Care
- Others
Regional Analysis
This section covers regional segmentation which accentuates on current and future demand for dry eye syndrome market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Dry Eye Syndrome Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the dry eye syndrome market include Allergan, Novartis AG, Otsuka Pharmaceutical Co. Ltd., Valent Pharmaceuticals, Johnson And Johnson Vision, Acadia Pharmaceutical, Allostera Pharma, I-Med Pharma Inc., Santen Pharmaceuticals Co. Ltd., AFT Pharmaceuticals, Others. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.